U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
Yesterday
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

March 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, including Factset, Lensar and Starbucks.

HIGHLIGHTS

* Factset FDS.N: RBC cuts target price to $243 from $320

* Lensar Inc LNSR.O: BTIG raises to buy from neutral

* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts to neutral from buy

* Starbucks SBUX.O: RBC cuts to sector perform from outperform

* Weatherford International Plc WFRD.O: RBC initiates coverage with outperform rating

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Academy Sports and Outdoors ASO.O: Barclays cuts target price to $49 from $59

* Academy Sports and Outdoors Inc ASO.O: Truist Securities cuts target to $52 from $59

* Academy Sports and Outdoors Inc ASO.O: UBS cuts target price to $56 from $60

* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts target price to $52 from $57

* Air Products APD.N: Argus Research raises target price to $316 from $265

* Aldeyra Therapeutics Inc ALDX.O: H.C. Wainwright cuts target price to $2 from $10

* Aldeyra Therapeutics Inc ALDX.O: H.C. Wainwright cuts to neutral from buy

* Alto Neuroscience Inc ANRO.N: Baird raises target price to $41 from $22

* Andersen Group Inc ANDG.N: Morgan Stanley raises target price to $24 from $22

* Andersen Group Inc ANDG.N: UBS raises target price to $32 from $28

* Apogee Therapeutics Inc APGE.O: Truist Securities initiates with hold rating

* Apogee Therapeutics Inc APGE.O: Truist Securities initiates with price target $83

* Arcturus Therapeutics Holdings Inc ARCT.O: B. Riley initiates with buy rating

* Arcturus Therapeutics Holdings Inc ARCT.O: B. Riley initiates with price target $22

* Arthur J. Gallagher & Co AJG.N: Truist Securities cuts target price to $235 from $271

* Bakkt Intermediate Holdings Inc BKKT.N: Benchmark cuts target price to $22 from $40

* BitGo Holdings Inc BTGO.N: Citigroup cuts target price to $17 from $18

* Blackline Inc BL.O: BMO cuts target price to $44 from $52

* Block Inc XYZ.N: Truist Securities raises to buy from hold; raises target price to $77 from $72

* Brightspring Health Services Inc BTSG.O: TD Cowen raises target price to $60 from $49

* Brightspring Health Services Inc BTSG.O: UBS raises target price to $55 from $53

* California Resources Corp CRC.N: Citigroup raises target price to $67 from $51

* Cal-Maine Foods Inc CALM.O: Stephens raises target price to $90 from $85

* Candel Therapeutics Inc CADL.O: Citigroup raises target price to $26 from $22

* Carnival Corp CCL.N: Deutsche Bank cuts target price to $34 from $36

* Celanese Corp CE.N: UBS raises target price to $58 from $56

* CF Industries Holdings CF.N: BMO raises target price to $140 from $115

* CF Industries Holdings CF.N: BofA Global Research ups price objective to $103 from $86

* CF Industries Holdings CF.N: Mizuho cuts to underperform from neutral

* CF Industries Holdings CF.N: Mizuho raises target price to $100 from $95

* Clean Harbors Inc CLH.N: Wells Fargo raises target price to $309 from $291

* Climb Bio CLYM.O: Truist Securities initiates coverage with buy rating and PT of $17

* Coherent Corp COHR.N: Stifel raises target price to $275 from $235

* Constellation Brands Inc STZ.N: Citigroup raises target price to $175 from $155

* Constellation Brands Inc STZ.N: Citigroup raises to buy from neutral

* Cytomx Therapeutics Inc CTMX.O: Jefferies raises target price to $16 from $8

* Dakota Gold Corp. DC.A: H.C. Wainwright raises target price to $10.50 from $9.75

* Digital Realty Trust Inc DLR.N: Barclays raises target price to $182 from $164

* Docusign Inc DOCU.O: JP Morgan cuts target price to $65 from $78

* Docusign Inc DOCU.O: Morgan Stanley cuts target price to $69 from $90

* Docusign Inc DOCU.O: UBS cuts target price to $54 from $75

* Docusign Inc DOCU.O: Wells Fargo cuts target price to $60 from $75

* DOW Inc DOW.N: UBS raises target price to $37 from $28

* DTE Energy DTE.N: Barclays raises target price to $156 from $151

* Duolingo Inc DUOL.O: Argus Research cuts to hold from buy

* Ecolab Inc ECL.N: Wells Fargo cuts target price to $285 from $310

* Entergy ETR.N: Citigroup raises target price to $116 from $106

* Equinix Inc EQIX.O: Barclays raises target price to $1,020 from $870

* Evommune Inc EVMN.N: H.C. Wainwright cuts target price to $50 from $65

* Factset FDS.N: RBC cuts target price to $243 from $320

* fair Isaac Corporation FICO.N: Wells Fargo cuts target price to $2,300 from $2,500

* Galaxy Digital Inc GLXY.O: Citigroup raises target price to $28 from $25

* Gemini Space Station Inc GEMI.O: Citigroup cuts target price to $5.5 from $13

* Gemini Space Station Inc GEMI.O: Citigroup cuts to sell from neutral

* Graham Corp GHM.N: Oppenheimer initiates coverage with outperform rating and PT $100

* Grail Inc GRAL.O: TD Cowen cuts target price to $65 from $114

* Grail Inc GRAL.O: TD Cowen raises to buy from hold

* Health Catalyst Inc HCAT.O: Wells Fargo cuts target price to $1 from $5

* Health Catalyst Inc HCAT.O: Wells Fargo cuts to equal weight from overweight

* Healthequity Inc HQY.O: RBC cuts target price to $100 from $110

* Highpeak Energy Inc HPK.O: Gerdes Energy Research cuts to sell from neutral

* IBM IBM.N: JP Morgan cuts target price to $283 from $317

* Knight-Swift Transportation Holdings Inc KNX.N: UBS raises target price to $66 from $54

* Knight-Swift Transportation Holdings Inc KNX.N: UBS raises to buy from neutral

* Landbridge Company Llc LB.N: Wells Fargo raises target price to $92 from $90

* Lennar Corp LEN.N: KBW cuts target price to $105 from $115

* Lensar Inc LNSR.O: BTIG raises to buy from neutral

* Lumentum Holdings Inc LITE.O: Morgan Stanley raises target price to $595 from $520

* Manpowergroup Inc MAN.N: Goldman Sachs raises to neutral from sell

* Maze Therapeutics Inc MAZE.O: Truist Securities initiates coverage with buy rating

* Maze Therapeutics Inc MAZE.O: Truist Securities initiates coverage with PT $68

* Micron Technology Inc MU.O: Bernstein raises target price to $510 from $330

* Moderna MRNA.O: Deutsche Bank raises target price to $45 from $28

* Monte Rosa Therapeutics Inc GLUE.O: Wells Fargo cuts target price to $29 from $30

* Navient Corp NAVI.O: Jefferies cuts target price to $9 from $13

* Netflix Inc NFLX.O: Citigroup resumes coverage with buy rating, price target $115

* Nuscale Power Corp SMR.N: UBS cuts target price to $13 from $20

* Nvidia Corp NVDA.O: Rosenblatt Securities raises target price to $325 from $300

* Nvidia Corp NVDA.O: Truist Securities raises target price to $287 from $283

* OGE Energy Corp OGE.N: Jefferies raises target price to $58 from $53

* Oklo Inc OKLO.N: B. Riley cuts target price to $92 from $129

* Oklo Inc OKLO.N: Canaccord Genuity cuts target price to $125 from $175

* Oklo Inc OKLO.N: Citigroup cuts target price to $73.5 from $95

* Oklo Inc OKLO.N: Needham cuts target price to $73 from $135

* Palantir Technologies Inc PLTR.O: UBS raises target price to $200 from $180

* Perpetua Resources Corp PPTA.O: B. Riley raises target price to $40 from $30

* Protagonist Therapeutics Inc PTGX.O: JP Morgan raises target price to $106 from $95

* PTC Inc PTC.O: Rosenblatt Securities cuts target price to $190 from $200

* Republic Services Inc RSG.N: Wells Fargo raises target price to $252 from $238

* Rhythm Pharmaceuticals Inc RYTM.O: H.C. Wainwright cuts target price to $100 from $110

* Riot Platforms Inc RIOT.O: Citigroup cuts target price to $21 from $23

* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts to neutral from buy

* SL Green Realty Corp SLG.N: Deutsche Bank cuts target price to $44 from $45

* SL Green Realty Corp SLG.N: Deutsche Bank raises to buy from hold

* Solaris Energy Infrastructure SEI.N: Barclays raises target price to $74 from $63

* Soleno Therapeutics SLNO.O: Oppenheimer cuts target price to $80 from $110

* Spyre Therapeutics Inc SYRE.O: Stifel raises target price to $92 from $70

* Starbucks SBUX.O: RBC cuts to sector perform from outperform

* Steel Dynamics Inc STLD.O: Wells Fargo cuts target price to $196 from $210

* Stoke Therapeutics Inc STOK.O: Wedbush raises target price to $38 from $36

* Strategy MSTR.O: Citigroup cuts target price to $260 from $325

* Telos Corp TLS.O: Wedbush cuts target price to $8 from $10

* Topbuild Corp BLD.N: D.A. Davidson cuts target price to $465 from $485

* Trade Desk Inc TTD.O: Rosenblatt Securities cuts target price to $25 from $36

* Trade Desk Inc TTD.O: Rosenblatt Securities cuts to neutral from buy

* Trade Desk Inc TTD.O: Stifel downgrades to hold from buy, cuts target to $26 from $48

* Trevi Therapeutics Inc TRVI.O: Morgan Stanley cuts target price to $18 from $19

* Vertex Pharmaceuticals Inc VRTX.O: Maxim Group raises to buy from hold

* Viavi Solutions Inc VIAV.O: Rosenblatt Securities raises target price to $42 from $27

* Warrior Met Coal Inc HCC.N: Citigroup raises target price to $100 from $80

* Waste Management Inc WM.N: Wells Fargo raises target price to $273 from $250

* Weatherford International Plc WFRD.O: RBC initiates coverage with outperform rating

* Weatherford International Plc WFRD.O: RBC initiates coverage with target price $105

* Westlake Corp WLK.N: UBS raises target price to $139 from $129

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10